ID

11995

Descripción

Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01649050

Link

https://clinicaltrials.gov/show/NCT01649050

Palabras clave

Versiones (1)
  1. 30/8/15 30/8/15 -
Subido en

30 de agosto de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050

Inglés

Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Diagnosis of multiple sclerosis (MS) of any type.
Descripción

Diagnosis of multiple sclerosis (MS) of any type.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026769
UMLS CUI [2]
C0332307
MS diagnosis at least 6 months prior to screening.
Descripción

MS diagnosis at least 6 months prior to screening.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011900
UMLS CUI [2]
C0026769
Stable MS with no relapse within 3 months prior to screening.
Descripción

Stable MS with no relapse within 3 months prior to screening.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0035020
Treated or untreated spasticity due to MS for at least 3 months prior to screening, not wholly relieved with antispasticity medications.
Descripción

Treated or untreated spasticity due to MS for at least 3 months prior to screening, not wholly relieved with antispasticity medications.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026838
UMLS CUI [2]
C0026769
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Patients with symptoms of spasticity not due to MS.
Descripción

Patients with symptoms of spasticity not due to MS.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026838
Patients taking three or more different anti-spasticity medications.
Descripción

Patients taking three or more different anti-spasticity medications.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013227
UMLS CUI [2]
C0026838
Acute MS exacerbation requiring treatment within 3 months of the Screening Visit.
Descripción

Acute MS exacerbation requiring treatment within 3 months of the Screening Visit.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0235874
UMLS CUI [2]
C0026769
Initiation of, or the discontinuation of interferon beta or any other disease modifying therapy for MS within 3 months of the Screening Visit.
Descripción

Initiation of, or the discontinuation of interferon beta or any other disease modifying therapy for MS within 3 months of the Screening Visit.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0015980
Use of baclofen pump at any time.
Descripción

Use of baclofen pump at any time.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3836732
Wheelchair or bed-bound patients.
Descripción

Wheelchair or bed-bound patients.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0043143
Volver a la parte superior de la página

Similar models

Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
multiple sclerosis; type
Item
Diagnosis of multiple sclerosis (MS) of any type.
boolean
C0026769 (UMLS CUI [1])
C0332307 (UMLS CUI [2])
diagnosis; multiple sclerosis
Item
MS diagnosis at least 6 months prior to screening.
boolean
C0011900 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
relapse
Item
Stable MS with no relapse within 3 months prior to screening.
boolean
C0035020 (UMLS CUI [1])
spasticity; multiple sclerosis
Item
Treated or untreated spasticity due to MS for at least 3 months prior to screening, not wholly relieved with antispasticity medications.
boolean
C0026838 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
spasticity
Item
Patients with symptoms of spasticity not due to MS.
boolean
C0026838 (UMLS CUI [1])
medications; spasticity
Item
Patients taking three or more different anti-spasticity medications.
boolean
C0013227 (UMLS CUI [1])
C0026838 (UMLS CUI [2])
Disease Exacerbation; multiple sclerosis
Item
Acute MS exacerbation requiring treatment within 3 months of the Screening Visit.
boolean
C0235874 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
interferon beta
Item
Initiation of, or the discontinuation of interferon beta or any other disease modifying therapy for MS within 3 months of the Screening Visit.
boolean
C0015980 (UMLS CUI [1])
baclofen pump
Item
Use of baclofen pump at any time.
boolean
C3836732 (UMLS CUI [1])
wheelchair
Item
Wheelchair or bed-bound patients.
boolean
C0043143 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial